Apellis Pharmaceuticals Inc (APLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | APLS | CRSP | MANE | ||
| Company | Apellis Pharmaceuticals Inc | Crispr Therapeutics Ag | Veradermics Incorporated | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | ||
| Open | 41.05 | 56.30 | 124.47 | ||
| High | 41.07 | 56.30 | 125.04 | ||
| Low | 41.03 | 52.05 | 117.00 | ||
| Latest | 41.03 | 53.35 | 119.60 | ||
| Change | -0.03 | -2.99 | -5.31 | ||
| % Change | -0.07% | -5.31% | -4.25% | ||
| Volume | 68,611,400 | 2,066,425 | 329,592 | ||
| 20-Day Average Volume | 7,541,190 | 1,729,031 | 738,014 | ||
| Previous Close | 41.06 | 56.34 | 124.91 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 40.97 | 55.04 | 111.99 | ||
| 20-Day Raw Stochastic | 67.65% | 30.01% | 73.79% | ||
| 20-Day Relative Strength | 81.66 | 48.19 | 58.22 | ||
| Weighted Alpha | +25.64 | -7.14 | N/A | ||
| Today's Opinion | 100% Buy | 8% Sell | N/A | ||
| Previous Opinion | 100% Buy | 40% Buy | N/A | ||
| Last Month's Opinion | 100% Buy | 88% Sell | N/A | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.22% since 05/06/26 | -11.20% since 07/02/26 | -7.82% since 07/02/26 | ||
| Low | 40.98 on 05/07/26 | 52.05 on 07/10/26 | 116.19 on 07/09/26 | ||
| High | 41.08 on 05/12/26 | 63.45 on 07/06/26 | 129.80 on 07/06/26 | ||
| 1-Month | |||||
| %Chg | +0.47% since 04/13/26 | +7.91% since 06/10/26 | +28.63% since 06/10/26 | ||
| Low | 40.78 on 04/14/26 | 49.02 on 06/11/26 | 86.83 on 06/18/26 | ||
| High | 41.14 on 05/06/26 | 63.45 on 07/06/26 | 131.24 on 07/01/26 | ||
| 3-Month | |||||
| %Chg | +89.08% since 02/13/26 | +4.16% since 04/10/26 | +73.84% since 04/10/26 | ||
| Low | 16.83 on 03/30/26 | 46.92 on 05/19/26 | 65.80 on 04/24/26 | ||
| High | 41.14 on 05/06/26 | 63.45 on 07/06/26 | 131.24 on 07/01/26 | ||
| 6-Month | |||||
| %Chg | +107.12% since 11/13/25 | -0.91% since 01/09/26 | N/A since 02/04/26 | ||
| Low | 16.83 on 03/30/26 | 44.12 on 03/30/26 | 32.00 on 02/04/26 | ||
| High | 41.14 on 05/06/26 | 63.45 on 07/06/26 | 131.24 on 07/01/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 5,252,701 | 5,433,936 | 5,218,614 | ||
| Shares Outstanding, K | 128,021 | 96,449 | 41,779 | ||
| Annual Sales | 1,003,780,000 | 3,510,000 | 0 | ||
| Annual Net Income | 22,390,000 | -581,600,000 | -70,000,000 | ||
| Last Quarter Sales | 268,300,000 | 1,460,000 | 0 | ||
| Last Quarter Net Income | 18,660,000 | -122,930,000 | -27,230,000 | ||
| 60-Month Beta | -0.24 | 1.71 | N/A | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.15 on 05/07/26 | -1.28 on 05/04/26 | -1.32 on 05/12/26 | ||
| Earnings Date | 07/30/26 | 08/03/26 | 08/11/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 40.25 | 0.00 | 0.00 | ||